Insiders who reported open-market trades in the last 12 months at the companies R. Jacob Vogelstein files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
R. Jacob Vogelstein is a corporate insider, tracked as Director of Iambic Therapeutics, Inc. (IAM). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has R. Jacob Vogelstein submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
InsiderAlpha's records for R. Jacob Vogelstein go back to 2026: 2 primary Form 4 filings, an average of 2.0 per year. 1 recorded transaction carries a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
